Uridine as an active component of sleep-promoting substance: its effects on nocturnal sleep in rats.
Honda. K K; Komoda. Y Y; Nishida. S S; Nagasaki. H H; Higashi. A A; Uchizono. K K; Inoué. S S
Key Findings
- A 10‑hour intracerebroventricular infusion of 10 pmol uridine increased total sleep time in rats, with a 21% rise in slow wave sleep and a 68% rise in REM sleep.
- The increase was due to more frequent sleep episodes, not longer episodes, and brain temperature remained unchanged.
- Very low (1 pmol) and very high (100‑1000 pmol) doses were ineffective or caused abnormal activity, indicating a narrow effective dose range.
Practical Outcomes
- For biohackers, the main takeaway is that uridine has the potential to enhance sleep, but the study used direct brain infusion—a method not applicable to humans. No oral or peripheral dosing information is provided, so translating this to a real‑world supplement protocol is speculative. Until human pharmacokinetic and safety data are available, uridine should be considered an interesting lead rather than a ready‑to‑use sleep aid.
Summary
In rats, directly delivering a tiny amount of uridine into the brain for 10 hours during the night boosted both deep (slow wave) and REM sleep, mainly by making sleep episodes happen more often. Small doses did nothing, and very large doses caused odd movement patterns, suggesting a sweet spot for effect. The study shows uridine can act as a sleep‑promoting agent in the brain, but it was tested only with invasive brain infusion in animals.
Abstract
A 10-h intraventricular infusion of 10 pmol of uridine from 19.00 to 05.00 h resulted in significant increases in sleep in otherwise saline-infused male rats (n = 8) during the environmental dark period (20.00-08.00 h). Increments of slow wave sleep (SWS) and paradoxical sleep (PS) were 21.0% and 68.1%, respectively, of the baseline value. This was due to increases in the frequencies of both SWS and PS episodes but not to their durations. Similar increases occurred the first recovery night under saline infusion, but sleep amounts returned to the baseline levels the second night. Brain temperature was not affected by uridine administration. A small dose of uridine (1 pmol/10 h) exerted no effect (n = 6) while larger doses (100 and 1000 pmol/10 h, each n = 5) resulted in slight but insignificant increases in SWS and PS. The 1000-pmol uridine administration seemed to be non-physiological since it brought about irregularities in locomotor activity and sleep-waking rhythms. Thus, authentic uridine exhibited the same sleep-enhancing effects as a naturally occurring active component of sleep-promoting substance, which was recently identified with uridine.
Study Information
pubmed
1984
10.1016/s0168-0102(84)80003-6